---
layout: page
permalink: /courses/mdcm790/mdcm790
exclude: true
---

## MDCM790

# Material

1. Introduction
    1. [What is cancer?](What_is_cancer.md)
    2. [Hallmarks of cancer](Hallmarks of cancer)
    3. [Cancer-driving mutations](mutations)
    4. [Oncogenes](oncogenes)
    5. [Chemotherapy principles](Chemotherapy principles.md)
2. Interfering with the DNA
    1. [DNA damage](DNA damage.md)
    2. [Topoisomerase inhibition](Topoisomerase inhibitors.md)
3. Interfering with the cytoskeleton
    1. [Microtubules](Microtubules.md)
    2. [Tubulin-binding drugs](Tubulin-binding drugs.md)
4. Transcription factors
    1. [Myc](Myc.md)
    2. [p53](p53 tumor suppressor.md)
    3. [Anti-hormone therapy](Anti-hormone therapy.md)
5. Signaling
    1. [Anti-growth factor](epidermal growth factor.md)
    2. [Ras](Ras protein.md) signaling
    3. [Anti-metabolites](Antimetabolites.md)
6. Interfering with [epigenetics](Epigenetic targets in cancer.md)
7. [Immunotherapy](Immunotherapy.md)
    1. [Engineered immune cells](CAR-T.md)
    2. Antibodies
    3. [Cyclin-dependent kinases](cyclin dependent kinases.md)
8. [Target degradation](Target degradation.md)
9. [Data portals for cancer research](Data portals.md)

# Research projects

1. [Mutations at the drug binding sites](project1.md)
2. [Metabolism and cancer](project2.md)
3. [Small molecules that cleave DNA](project3.md)
4. [Histone "code"](project4.md)
5. [Discovering cancer dependencies from data](project5.md)
6. [Recent covalent cancer drugs](project6.md)
7. [CAR-T therapy](project7.md)
